Interferon-α therapy in patients dually infected with hepatitis C virus and GB virus C/hepatitis G virus - Virological response of HGV and pretreatment HGV viremia level

Journal of Hepatology

Volumn 27, Issue 4, 1997, Pages 603-612

  Orito, Etsuro ^a   Mizokami, Masashi ^a   Yasuda, Kiyomi ^b   Sugihara, Kanji ^c   Nakamura, Makoto ^c   Mukaide, Motokazu ^d   Ohba, Ken Ichi ^a   Nakano, Tatsunori ^a   Kato, Takanobu ^a   Kondo, Yutaka ^a   Kumada, Takashi ^e   Ueda, Ryuzo ^a   Iino, Shiro ^f  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Kiyokawa Hospital   (Japan)

^c Yoyokawa City Hospital   (Japan)

^d SRL INC   (Japan)

^e OGAKI MUNICIPAL HOSPITAL   (Japan)

^f ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

GBV C; HCV; HGV; HGV genotype; HGV viremia; IFN therapy; Response

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS CHARACTERIZATION; VIRUS HEPATITIS;

EID: 0030768403     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80076-1     Document Type: Article

References (28)

1. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med. 1:1995;564-569.
2. Linnen J, Wages J Jr., Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 271:1996;505-508.
3. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol. 48:1996;60-67.
4. Ohba KI, Mizokami M, Lau JY, Orito E, Ikeo K, Gojobori T. Evolutionary relationship of hepatitis C, pesti-, flavi-, plantviruses, and newly discovered GB hepatitis agents. FEBS Lett. 378:1996;232-234.
5. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med. 334:1996;195-196.
6. Nishiyama Y, Nakashima H, Hino K, Mori K, Ishikawa M, Okamoto H. Infection with hepatitis GB virus among Japanese hemophiliacs. Transfusion. 36:1996;669.
7. Kudo T, Morishima T, Tsuzuki K, Orito E, Mizokami M. Hepatitis G virus in immunosuppressed paediatric allograft recipients. Lancet. 348:1996;751.
8. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med. 334:1996;1485-1490.
9. Orito E, Mizokami M, Nakano T, Wu RR, Cao K, et al. GB virus C/hepatitis G virus infection among Japanese patients with chronic liver diseases and blood donors. Virus Res. 46:1996;89-93.
10. Wu RR, Mizokami M, Cao K, Nakano T, Ge XM, Wang SS, et al. GB virus C/hepatitis G virus infection in Southern China. J Infect Dis. 175:1997;168-171.
11. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr., Perrillo RP. Treatment of chronic hepatitis C with recombinant interferon alfa: multicenter randomized, controlled trial. N Engl J Med. 321:1989;151-1506.
12. Lau JYN, Davis GL, Knniffen J, Qian KP, Urdea MS, Chan CS, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
13. Yoshioka K, Kakumu S, Wakita T, Itoh Y, Takayanagi M, Higashi Y, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alfa therapy: relationship to genotypes of hepatitis C virus. Hepatology. 16:1992;293-299.
14. Orito E, Mizokami M, Nakano T, Terashima H, Nojiri O, Sakakibara K, et al. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C. J Med Virol. 44:1994;410-414.
15. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med. 60:1990;215-222.
16. Tanaka T, Lau JYN, Mizokami M, Orito E, Tanaka E, Kiyosawa K, et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatol. 23:1995;742-745.
17. Orito E, Mizokami M, Tanaka T, Lau JYN, Suzuki K, Yamauchi M, et al. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C genotypes. Gut. 39:1996;876-880.
18. Tanaka T, Tsukiyama-Kohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A, et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology. 19:1994;1347-1353.
19. Ohno T, Mizokami M, Wu RR, Saleh MG, Ohba KI, Orito E, et al. A new hepatitis C virus genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 4, 5a, and 6a. J Clin Microbiol. 35:1997;201-207.
20. Mukaide M, Mizokami M, Orito E, Ohba KI, Nakano T, Ueda R, et al. Three different GB virus C/hepatitis G virus genotypes - phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett. 407:1997;51-58.
21. Kao JH, Chen PJ, Hsiang SC, Chen W, Chen DS. Phylogenetic analysis of GB virus C: comparison of isolates from Africa, North America, and Taiwan. J Infect Dis. 174:1996;410-413.
22. Muerhoff AS, Simons JN, Leary TP, Erker JC, Chalmers ML, Pilot-Matias TJ, et al. Sequence heterogeneity within the 5′-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol. 25:1996;379-384.
23. Colombatto P, Randone A, Civitico G, Gorin JM, Dolci L, Medaina N, et al. Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease. J Virol Hepatol. 3:1996;301-306.
24. Tanaka E, Alter HJ, Nakatsuji Y, Shih JWK, Kim JP, Matsumoto A, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med. 125:1996;740-743.
25. Berg T, Dirla U, Naumann U, Heuft HG, Kuther S, Lobeck H, et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol. 25:1996;763-768.
26. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, et al. Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol. 46:1995;109-115.
27. Kakumu S, Yoshioka K, Tanaka K, Higashi Y, Kurokawa S, Hirofuji H, et al. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C. J Med Virol. 41:1993;65-70.
28. Byrnes JJ, Banks AT, Piatack M, Kim JSP. Hepatitis G-associated aplastic anaemia. Lancet. 348:1996;472.